Use of everolimus as an alternative to calcineurin inhibitors in renal allograft recipients: A single South Indian center's experience

Use of everolimus as an alternative to calcineurin inhibitors in renal allograft recipients: A single South Indian center's experience

Introduction: Chronic Renal Allograft Injury(CRAI) is the most important cause of chronic graft dysfunction and loss. Calcineurin inhibitors (CNI) have been the back bone for immunosuppressive therapy, but their adverse effects can directly contribute to CRAI and compromise long-term renal allograft...

Full description

Bibliographic Details
Main Authors: Manns Manohar John, Mahesh Eswarappa, Gurudev K Chennabasappa, Gireesh M Siddiah, R Rajashekar, Vivek Gaurav
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Transplantation
Subjects:
Calcineurin inhibitors
everolimus
rejection
renal transplant
Online Access:http://www.ijtonline.in/article.asp?issn=2212-0017;year=2019;volume=13;issue=2;spage=118;epage=121;aulast=John

Internet

http://www.ijtonline.in/article.asp?issn=2212-0017;year=2019;volume=13;issue=2;spage=118;epage=121;aulast=John

Similar Items